Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 95

1.

Improving skin quality in patients with dermatologic conditions using the hyaluronic acid filler VYC-12.

Proietti I, Skroza N, Potenza C.

G Ital Dermatol Venereol. 2020 Mar 3. doi: 10.23736/S0392-0488.19.06453-8. [Epub ahead of print] No abstract available.

PMID:
32129049
2.

Creation of a severity index for hidradenitis suppurativa that includes a validated quality-of-life measure: the HIDRAscore.

Marzano AV, Chiricozzi A, Giovanardi G, Argenziano G, Bettoli V, Bianchi L, Dapavo P, Dini V, Fabbrocini G, Micali G, Offidani AM, Potenza C, Prignano F, Gualberti G, Saragaglia V, Rongioletti F.

J Eur Acad Dermatol Venereol. 2020 Mar 2. doi: 10.1111/jdv.16328. [Epub ahead of print]

PMID:
32119143
3.

A Rare BRAF V600E mutation detected by Next Generation Sequencing in a superficial spreading melanoma: case report and potential diagnostic implications.

Proietti IC, Michelini S, Di Fraia M, Mambrin A, Petrozza V, Porta N, Pacini L, Calogero A, Skroza N, Potenza C.

J Eur Acad Dermatol Venereol. 2020 Feb 13. doi: 10.1111/jdv.16294. [Epub ahead of print]

PMID:
32056293
4.

Clinical and histopathological characterization of eczematous eruptions occurring in course of anti IL-17 treatment: a case series and review of the literature.

Caldarola G, Pirro F, Di Stefani A, Talamonti M, Galluzzo M, D'Adamio S, Magnano M, Bernardini N, Malagoli P, Bardazzi F, Potenza C, Bianchi L, Peris K, De Simone C.

Expert Opin Biol Ther. 2020 Feb 17:1-8. doi: 10.1080/14712598.2020.1727439. [Epub ahead of print]

PMID:
32045273
5.

Black and Pink: Single Lesion or Double Diagnosis?

Proietti I, Di Fraia M, Michelini S, Colapietra D, Rullo E, Porta N, Petrozza V, Skroza N, Potenza C.

Dermatol Pract Concept. 2019 Dec 31;10(1):e2020025. doi: 10.5826/dpc.1001a25. eCollection 2020. No abstract available.

6.

Ingenol mebutate therapy in erythroplasia of Queyrat: a new approach.

Proietti I, Michelini S, Skroza N, Bernardini N, Tolino E, Anzalone A, Colapietra D, Mambrin A, Di Fraia M, Marchesiello A, Balduzzi V, Porta N, Petrozza V, Potenza C.

G Ital Dermatol Venereol. 2019 Dec 4. doi: 10.23736/S0392-0488.19.06371-5. [Epub ahead of print]

PMID:
31804047
7.

On the role of skin biopsy in the diagnosis of calcific uremic arteriolopathy: a case-based discussion.

Rotondi S, De Martini N, Tartaglione L, Muci ML, Petrozza V, Porta N, Leopizzi M, Proietti I, Potenza C, Skroza N, Mazzaferro S.

J Nephrol. 2019 Dec 2. doi: 10.1007/s40620-019-00678-z. [Epub ahead of print]

PMID:
31792896
8.

Ixekizumab Effectiveness and Safety in the Treatment of Moderate-to-Severe Plaque Psoriasis: A Multicenter, Retrospective Observational Study.

Chiricozzi A, Burlando M, Caldarola G, Conti A, Damiani G, De Simone C, Dini V, Malagoli P, Peccerillo F, Potenza C, Scala E, Skroza N, Balato A.

Am J Clin Dermatol. 2019 Nov 30. doi: 10.1007/s40257-019-00490-2. [Epub ahead of print]

PMID:
31786732
9.

IL-17 and its role in inflammatory, autoimmune, and oncological skin diseases: state of art.

Bernardini N, Skroza N, Tolino E, Mambrin A, Anzalone A, Balduzzi V, Colapietra D, Marchesiello A, Michelini S, Proietti I, Potenza C.

Int J Dermatol. 2020 Apr;59(4):406-411. doi: 10.1111/ijd.14695. Epub 2019 Oct 30. Review.

PMID:
31663126
10.

Real-life experience on effectiveness and safety of dupilumab in adult patients with moderate-to-severe atopic dermatitis.

Fargnoli MC, Esposito M, Ferrucci S, Girolomoni G, Offidani A, Patrizi A, Peris K, Costanzo A, Malara G, Pellacani G, Romanelli M, Amerio P, Cristaudo A, Flori ML, Motolese A, Betto P, Patruno C, Pigatto P, Sirna R, Stinco G, Zalaudek I, Bianchi L, Boccaletti V, Cannavò SP, Cusano F, Lembo S, Mozzillo R, Gallo R, Potenza C, Rongioletti F, Tiberio R, Grieco T, Micali G, Persechino S, Pettinato M, Pucci S, Savi E, Stingeni L, Romano A, Argenziano G; Dupilumab Italian National Access Program (Dup-INAP group).

J Dermatolog Treat. 2019 Oct 28:1-7. doi: 10.1080/09546634.2019.1682503. [Epub ahead of print]

PMID:
31647347
11.

A case of hidradenitis suppurativa linked to trisomy 1q.

Skroza N, Mambrin A, Tolino E, Bernardini N, Proietti I, Anzalone A, Marchesiello A, Porta N, Petrozza V, Potenza C.

J Eur Acad Dermatol Venereol. 2019 Oct;33 Suppl 6:32-33. doi: 10.1111/jdv.15824.

PMID:
31535764
12.

Eruptive Blue Nevi of the Scalp in a Patient with Mayer-Rokitansky-Küster-Hauser Syndrome during Isotretinoin Therapy.

Skroza N, Proietti I, Tolino E, Bernardini N, Balduzzi V, Marchesiello A, Anzalone A, Colapietra D, Michelini S, Mambrin A, Porta N, Petrozza V, Potenza C.

Indian J Dermatol. 2019 Jul-Aug;64(4):339. doi: 10.4103/ijd.IJD_188_18. No abstract available.

13.

The Skin in Celiac Disease Patients: The Other Side of the Coin.

Abenavoli L, Dastoli S, Bennardo L, Boccuto L, Passante M, Silvestri M, Proietti I, Potenza C, Luzza F, Nisticò SP.

Medicina (Kaunas). 2019 Sep 9;55(9). pii: E578. doi: 10.3390/medicina55090578. Review.

14.

Interleukin-17A affects extracellular vesicles release and cargo in human keratinocytes.

Mangino G, Iuliano M, Carlomagno S, Bernardini N, Rosa P, Chiantore MV, Skroza N, Calogero A, Potenza C, Romeo G.

Exp Dermatol. 2019 Sep;28(9):1066-1073. doi: 10.1111/exd.14015.

PMID:
31373041
15.

The increase of mTOR expression is consistent with FoxO1 decrease at gene level in acne but not in psoriasis.

Lembo S, Di Caprio R, Balato A, Caiazzo G, Fabbrocini G, Skroza N, Tolino E, Potenza C.

Arch Dermatol Res. 2020 Jan;312(1):77-80. doi: 10.1007/s00403-019-01959-0. Epub 2019 Jul 31. No abstract available.

PMID:
31367853
16.

Post acne scarring: which factors are involved?

Tolino E, Skroza N, Proietti I, Bernardini N, Balduzzi V, Anzalone A, La Torre G, Marchesiello A, Mambrin A, Potenza C.

G Ital Dermatol Venereol. 2019 Jul 12. doi: 10.23736/S0392-0488.19.06154-6. [Epub ahead of print] No abstract available.

PMID:
31302974
17.

Face and Scalp Basal Cell Carcinoma Treatment: A Review of the Literature.

Bernardini N, Skroza N, Zuber S, Tolino E, Balduzzi V, Mambrin A, Marchesiello A, Anzalone A, Colapietra D, Proietti I, Potenza C.

Acta Dermatovenerol Croat. 2019 Mar;27(1):22-27. Review.

PMID:
31032787
18.

Secukinumab shows high efficacy irrespective of HLA-Cw6 status in patients with moderate-to-severe plaque-type psoriasis: results from extension phase of the SUPREME study.

Papini M, Cusano F, Romanelli M, Burlando M, Stinco G, Girolomoni G, Peris K, Potenza C, Offidani A, Bartezaghi M, Aloisi E, Costanzo A; SUPREME study group.

Br J Dermatol. 2019 Aug;181(2):413-414. doi: 10.1111/bjd.18013. Epub 2019 May 29. No abstract available.

PMID:
31001812
19.

A tailored therapeutic approach for patients affected by multi-drug resistant Psoriasis.

Bernardini N, Skroza N, Mambrin A, Tolino E, Anzalone A, Balduzzi V, Colapietra D, Marchesiello A, Michelini S, Zuber S, Proietti I, Potenza C.

G Ital Dermatol Venereol. 2019 Jan 15. doi: 10.23736/S0392-0488.19.06048-6. [Epub ahead of print] No abstract available.

PMID:
30648832
20.

HIDRAdisk: validation of an innovative visual tool to assess the burden of hidradenitis suppurativa.

Peris K, Lo Schiavo A, Fabbrocini G, Dini V, Patrizi A, Fusano M, Bianchi L, Guanziroli E, Guarneri C, Parodi A, Bertoldi A, Musumeci ML, Offidani A, Rongioletti F, Pistone G, Malara G, Potenza C, Casari A, Franchi C, Ardigò M, Cusano F, Stingeni L, Amerio P, Mancini LL, Prignano F, Deboli T, Gualberti G, Saragaglia V, Bettoli V.

J Eur Acad Dermatol Venereol. 2019 Apr;33(4):766-773. doi: 10.1111/jdv.15425. Epub 2019 Mar 5.

21.

Clinical utility of ingenol mebutate in the management of actinic keratosis: perspectives from clinical practice.

Skroza N, Bernardini N, Proietti I, Potenza C.

Ther Clin Risk Manag. 2018 Oct 4;14:1879-1885. doi: 10.2147/TCRM.S145779. eCollection 2018. Review.

22.

A Review of the Literature of Surgical and Nonsurgical Treatments of Invasive Squamous Cells Carcinoma.

Potenza C, Bernardini N, Balduzzi V, Losco L, Mambrin A, Marchesiello A, Tolino E, Zuber S, Skroza N, Proietti I.

Biomed Res Int. 2018 Apr 2;2018:9489163. doi: 10.1155/2018/9489163. eCollection 2018. Review.

23.

Psoriasis Area and Severity Index response in moderate-severe psoriatic patients switched to adalimumab: results from the OPPSA study.

Talamonti M, Galluzzo M, Bernardini N, Caldarola G, Persechino S, Cantoresi F, Egan CG, Potenza C, Peris K, Bianchi L.

J Eur Acad Dermatol Venereol. 2018 Oct;32(10):1737-1744. doi: 10.1111/jdv.15077. Epub 2018 Jun 1.

PMID:
29776016
24.

Efficacy and tolerability of a lotion containing triethyl citrate, ethyl linoleate, and GT peptide-10 in the adjuvant treatment of hidradenitis suppurativa: Real-life data.

Skroza N, Mambrin A, Tolino E, Marchesiello A, Proietti I, Bernardini N, Potenza C.

Dermatol Ther. 2018 Jul;31(4):e12599. doi: 10.1111/dth.12599. Epub 2018 Apr 11.

PMID:
29642279
25.

Dermoscopic features of milia-like calcinosis cutis.

Proietti I, Bernardini N, Mambrin A, Tolino E, Mancini M, Petrozza V, Potenza C.

G Ital Dermatol Venereol. 2019 Dec;154(6):724-725. doi: 10.23736/S0392-0488.18.05840-6. Epub 2018 Mar 6. No abstract available.

PMID:
29512978
26.

Cutis marmorata telangiectatica congenita: a diagnostic challenge.

Proietti I, Bernardini N, Balduzzi V, Marchesiello A, Zuber S, Mancini M, Petrozza V, Potenza C.

G Ital Dermatol Venereol. 2020 Feb;155(1):108-110. doi: 10.23736/S0392-0488.18.05837-6. Epub 2018 Mar 6. No abstract available.

PMID:
29512977
27.

Novel combination for the treatment of acne differentiated based on gender: a new step towards personalized treatment.

Tolino E, Skroza N, Mambrin A, Bernardini N, Zuber S, Balduzzi V, Marchesiello A, Proietti I, Potenza C.

G Ital Dermatol Venereol. 2018 Dec;153(6):866-871. doi: 10.23736/S0392-0488.18.05710-3. Epub 2018 Feb 7.

PMID:
29417793
28.

Adult Acne Versus Adolescent Acne: A Retrospective Study of 1,167 Patients.

Skroza N, Tolino E, Mambrin A, Zuber S, Balduzzi V, Marchesiello A, Bernardini N, Proietti I, Potenza C.

J Clin Aesthet Dermatol. 2018 Jan;11(1):21-25. Epub 2018 Jan 1.

29.

Prevalence and risk factors of actinic keratosis in patients attending Italian dermatology clinics.

Fargnoli MC, Altomare G, Benati E, Borgia F, Broganelli P, Carbone A, Chimenti S, Donato S, Girolomoni G, Micali G, Moggio E, Parodi A, Piaserico S, Pistone G, Potenza C, Puviani M, Raucci M, Vaccari S, Veglio S, Zanca A, Peris K.

Eur J Dermatol. 2017 Dec 1;27(6):599-608. doi: 10.1684/ejd.2017.3126.

PMID:
29311040
30.

Biologic agents perception in patients attending for the first-time to psoriasis centers: a multicenter Italian survey.

Luca M, Musumeci ML, Bardazzi F, Potenza C, Bernardini N, Ferrara F, Pavone A, Micali G.

G Ital Dermatol Venereol. 2017 Nov 30. doi: 10.23736/S0392-0488.17.05754-6. [Epub ahead of print]

PMID:
29192471
31.

Factors influencing response to ingenol mebutate therapy for actinic keratosis of face and scalp.

Skroza N, Proietti I, Bernardini N, Balduzzi V, Mambrin A, Marchesiello A, Tolino E, Zuber S, La Torre G, Potenza C.

World J Clin Oncol. 2017 Oct 10;8(5):405-411. doi: 10.5306/wjco.v8.i5.405.

32.

Biologic Therapies in HIV-infected Patients with Psoriasis: An Italian Experience.

Bardazzi F, Magnano M, Campanati A, Loconsole F, Carpentieri A, Potenza C, Bernardini N, Di Lernia V, Carrera C, Raone B, Patrizi A, Loi C.

Acta Derm Venereol. 2017 Aug 31;97(8):989-990. doi: 10.2340/00015555-2698. No abstract available.

33.

Effects of TNFα inhibitors in patients with psoriasis and metabolic syndrome: a preliminary study.

Merlo G, Cozzani E, Burlando M, Calvieri S, Potenza C, Stingeni L, Filosa G, Pau M, Simonacci M, Caproni M, Parodi A.

G Ital Dermatol Venereol. 2020 Feb;155(1):14-18. doi: 10.23736/S0392-0488.17.05621-8. Epub 2017 Apr 19.

PMID:
28421729
34.

Unknown Primary Melanoma: Worldwide Survey on Clinical Management.

Ribero S, Pampena R, Bataille V, Moscarella E, Thomas L, Quaglino P, Potenza C, Van Akkooi ACJ, Testori A, Nathan P, Puig S, Zalaudek I, Argenziano G, Longo C.

Dermatology. 2016;232(6):704-707. doi: 10.1159/000453592. Epub 2017 Jan 5.

PMID:
28052277
35.

Erythroplasia of Queyrat treated with methyl aminolevulinate-photodynamic therapy.

Skroza N, La Viola G, Pampena R, Proietti I, Bernardini N, Tolino E, Annetta A, Zuber S, Balduzzi V, Potenza C.

G Ital Dermatol Venereol. 2020 Feb;155(1):103-106. doi: 10.23736/S0392-0488.16.05163-4. Epub 2016 Dec 1.

PMID:
27905695
36.

Cardiovascular risk evaluation through heart rate variability analysis in psoriatic patients before and after 24 weeks of etanercept therapy: Prospective study.

Potenza C, Raimondi G, Pampena R, Proietti I, Viola G, Bernardini N, Tolino E, Zuber S, Balduzzi V, Scordamaglia B, Skroza N.

J Int Med Res. 2016 Sep;44(1 suppl):43-47.

37.

Cardiovascular Risk Evaluation through Heart Rate Variability (HRV) Analysis in Patients with Psoriasis before and after 12 Weeks of Etanercept Therapy: A Preliminary Prospective Study.

Potenza C, Raimondi G, Pampena R, Bernardini N, La Viola G, Tolino E, Zuber S, Scordamaglia B, Skroza N.

Acta Dermatovenerol Croat. 2016 Aug;24(3):181-6.

PMID:
27663918
38.

Living with Chronic Spontaneous Urticaria in Italy: A Narrative Medicine Project to Improve the Pathway of Patient Care.

Cappuccio A, Limonta T, Parodi A, Cristaudo A, Bugliaro F, Cannavò SP, Rossi O, Gurioli C, Vignoli A, Parente R, Iemoli E, Caldarola G, De Pità O, Di Nuzzo S, Cancian M, Potenza C, Caminati M, Stingeni L, Saraceno R, Trevisini S, Piccirillo A, Sciarrone C, Panebianco R, Gola M, Costanzo A, Grieco T, Massaroni K, Reale L, Marini MG.

Acta Derm Venereol. 2017 Jan 4;97(1):81-85. doi: 10.2340/00015555-2478.

39.

IL12B (p40) Gene Polymorphisms Contribute to Ustekinumab Response Prediction in Psoriasis.

Galluzzo M, Boca AN, Botti E, Potenza C, Malara G, Malagoli P, Vesa S, Chimenti S, Buzoianu AD, Talamonti M, Costanzo A.

Dermatology. 2016;232(2):230-6. doi: 10.1159/000441719. Epub 2015 Dec 18.

PMID:
26678060
40.

Large Nosocomial Outbreak Associated with a Norwegian Scabies Index Case Undergoing TNF-α Inhibitor Treatment: Management and Control.

Belvisi V, Orsi GB, Del Borgo C, Fabietti P, Ianari A, Albertoni F, Porcelli P, Potenza C, Mastroianni CM.

Infect Control Hosp Epidemiol. 2015 Nov;36(11):1358-60. doi: 10.1017/ice.2015.188. Epub 2015 Aug 19.

PMID:
26288185
41.

Psoriasis awareness among Italian patients: results of a nationwide survey.

Bardazzi F, Amerio P, Amoruso G, Campanati A, Conti A, De Simone C, Gisondi P, Gualdi G, Guarneri C, Loconsole F, Mazzotta A, Musumeci ML, Piaserico S, Potenza C, Scudeller L; Alphard study.

G Ital Dermatol Venereol. 2016 Feb;151(1):1-8. Epub 2015 Mar 9.

PMID:
25747259
42.

Investigating psoriasis awareness among patients in Italy: validation of a questionnaire.

Bardazzi F, Amerio P, Amoruso G, Campanati A, Conti A, De Simone C, Gisondi P, Gualdi G, Guarneri C, Loconsole F, Mazzotta A, Musumeci ML, Odorici G, Piaserico S, Potenza C, Scudeller L; Alphard Study Group.

Eur Rev Med Pharmacol Sci. 2014 Nov;18(22):3435-52.

43.

Cardiovascular risk in psoriatic patients detected by heart rate variability (HRV) analysis.

Proietti I, Raimondi G, Skroza N, Pampena R, Bernardini N, La Viola G, Nicolucci F, Tolino E, Zuber S, Scordamaglia B, Balduzzi V, Soccodato V, Potenza C.

Drug Dev Res. 2014 Nov;75 Suppl 1:S81-4. doi: 10.1002/ddr.21204.

PMID:
25381987
44.

Women and acne: any difference from males? A review of the literature.

Skroza N, Tolino E, Proietti I, Bernardini N, La Viola G, Nicolucci F, Pampena R, Zuber S, Balduzzi V, Soccodato V, Mancini MT, Potenza C.

G Ital Dermatol Venereol. 2016 Feb;151(1):87-92. Epub 2014 Sep 18. Review.

PMID:
25236316
45.

Metabolic syndrome prevalence in psoriasis: a cross-sectional study in the Italian population.

Parodi A, Aste N, Calvieri C, Cantoresi F, Carlesimo M, Fabbri P, Filosa G, Galluccio A, Lisi P, Micali G, Potenza C, Richetta A, Simonacci M, Trevisan P, Valenti G, Calvieri S.

Am J Clin Dermatol. 2014 Aug;15(4):371-7. doi: 10.1007/s40257-014-0074-8.

PMID:
24756247
46.

BRAF and NRAS mutations are heterogeneous and not mutually exclusive in nodular melanoma.

Chiappetta C, Proietti I, Soccodato V, Puggioni C, Zaralli R, Pacini L, Porta N, Skroza N, Petrozza V, Potenza C, Della Rocca C, Di Cristofano C.

Appl Immunohistochem Mol Morphol. 2015 Mar;23(3):172-7. doi: 10.1097/PAI.0000000000000071.

47.

Isotretinoin for the treatment of squamous cell carcinoma arising on an epidermoid cyst.

Skroza N, Proietti I, Tolino E, Bernardini N, La Viola G, Nicolucci F, Pampena R, Mancini MT, Balduzzi V, Potenza C, Zuber S.

Dermatol Ther. 2014 Mar-Apr;27(2):94-6. doi: 10.1111/dth.12062. Epub 2013 May 21. Erratum in: Dermatol Ther. 2014 Jul-Aug;27(4):255. Zuber, Sara [added].

PMID:
24703265
48.

Optimization of systemic treatments for chronic plaque psoriasis. Recommendations for switching and transitioning.

Gisondi P, Amerio P, Amoroso GF, Antonucci VA, Bardazzi F, Buongiorno MR, Bruni P, Campanati A, Caproni M, Carlesimo M, Carrera CG, Cianchino G, Cimmino G, Costanzo A, Cozzani E, Dapavo P, D'amico D, De Simone C, Del Giglio M, Di Nuzzo S, Gai F, Galluccio AG, Goffredo A, Gualdi G, Guarneri C, Kokelj F, Lasagni C, Loconsole F, Longo V, Malagoli P, Miracapillo A, Mugheddu C, Parodi A, Pellegrino M, Peserico A, Piaserico S, Pistone G, Potenza C, Plumari A, Stingeni L, Strippoli D, Travaglino M, Girolomoni G.

G Ital Dermatol Venereol. 2013 Dec;148(6 Suppl 1):1-10.

PMID:
24675369
49.

Efficacy of food supplement to improve metabolic syndrome parameters in patients affected by moderate to severe psoriasis during anti-TNFα treatment.

Skroza N, Proietti I, Bernardini N, La Viola G, Nicolucci F, Pampena R, Tolino E, Zuber S, Mancini MT, Soccodato V, Balduzzi V, Potenza C.

G Ital Dermatol Venereol. 2013 Dec;148(6):661-5.

PMID:
24442048
50.

Immunogenicity of anti-TNFα therapy in psoriasis: a clinical issue?

De Simone C, Amerio P, Amoruso G, Bardazzi F, Campanati A, Conti A, Gisondi P, Gualdi G, Guarneri C, Leoni L, Loconsole F, Mazzotta A, Musumeci ML, Piaserico S, Potenza C, Prestinari F.

Expert Opin Biol Ther. 2013 Dec;13(12):1673-82. doi: 10.1517/14712598.2013.848194. Epub 2013 Oct 10. Review.

PMID:
24107126

Supplemental Content

Loading ...
Support Center